• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    STAAR Surgical Company - Common Stock (NQ:STAA)

    27.45 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, May 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about STAAR Surgical Company - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    STAAR Surgical Issues Shareholder Letter
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory
    From Yunqi Capital Limited
    Via Business Wire
    News headline image
    Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer
    From Yunqi Capital Limited
    Via Business Wire
    News headline image
    Broadwood Partners Responds to Alcon’s Increase to Proposed Acquisition Price of STAAR Surgical
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    STAAR Surgical Announces Expiration of Go-Shop Period
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process
    From Broadwood Partners, L.P.
    Via Business Wire
    News headline image
    STAAR Surgical Announces Amendments to Alcon Merger Agreement
    From STAAR Surgical Company
    Via Business Wire
    News headline image
    Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated
    From Yunqi Capital Limited
    Via Business Wire
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.